Immunoregulatory compositions
Abstract
The invention relates to compounds exhibiting immuno-regulatory activity as determined by measuring the compound's ability to modulate production of NO by a cell. Preferred compounds include or consist of a sequence AAL AAQ AAG AAV wherein AAL is a substituted or unsubstituted non-polar amino acid selected from the group consisting of Ala and Leu; wherein AAQ is a substituted or unsubstituted amino acid selected from the group consisting of Gln, Pro, and Ala; wherein AAG is a substituted or unsubstituted amino acid Gly, and wherein AAV is a substituted or unsubstituted non-polar amino acid selected from the group consisting of Val and Ala. In one embodiment, the compound consists of a tripeptide selected from the group AQG, MTR, VVC, and mixtures thereof.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1. A composition comprising one or more purified or isolated peptides of the sequence AQGV (SEQ ID NO:2).Join the waitlist — get patent alerts
Track USRE43309E — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.